Stressor-Induced Alteration of Cytokine Production in Multiple Sclerosis Patients and Controls

Objective We administered an acute psychological stressor to multiple sclerosis (MS) patients and normal controls to determine whether differences in subjective and physiological responses to stress may underlie the susceptibility of MS patients to stress-related exacerbations. Method Twenty-five MS patients (18 female, 7 male) and 25 age- and gender-matched controls participated in the study. They were asked to give a 5-minute videotaped speech defending themselves in a hypothetical scenario in which they were wrongly accused of stealing. Subjective and autonomic responses were monitored, and blood was sampled at baseline, 5, 20, and 60 minutes after the stressor to assess mitogen-stimulated production of interleukin-1 beta (IL-1 beta), interleukin-4 (IL-4), tumor necrosis factor-alpha (TNF-alpha), and interferon-gamma (IFN-gamma). Results MS patients and controls demonstrated similar subjective and physiological responses to the stressor that were independent of gender, mood, and disability status. The macrophage-derived cytokines IL-1 beta and TNF-alpha were increased during the stressor, and remained elevated through 60 minutes. Th1 lymphocyte-derived IFN-gamma production also was increased at 5 and 60 minutes relative to baseline; however, there was no change in the Th2 lymphocyte-derived cytokine IL-4. Conclusions These results favor the hypothesis that MS patients do not differ in stress response from normal controls; however, psychological stress may enhance cellular immune responses that would be potentially harmful to MS patients.

[1]  H. Kirchner,et al.  Increased production of interferon gamma and tumor necrosis factor precedes clinical manifestation in multiple sclerosis: Do cytokines trigger off exacerbations? , 1988, Acta neurologica Scandinavica.

[2]  T. Marunouchi,et al.  Cytokine production by peripheral blood monocytes/macrophages in multiple sclerosis patients , 1993, Acta neurologica Scandinavica.

[3]  Laurie H Glimcher,et al.  B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: Application to autoimmune disease therapy , 1995, Cell.

[4]  G. Evans,et al.  Social support lowers cardiovascular reactivity to an acute stressor. , 1993, Psychosomatic medicine.

[5]  G. A. Mccain,et al.  Cytokine production and lymphocyte transformation during stress , 1991, Brain, Behavior, and Immunity.

[6]  T. Olsson,et al.  Autoreactive T and B cells responding to myelin proteolipid protein in multiple sclerosis and controls , 1991, European journal of immunology.

[7]  T. Patterson,et al.  Severely threatening events and marked life difficulties preceding onset or exacerbation of multiple sclerosis. , 1989, Journal of neurology, neurosurgery, and psychiatry.

[8]  A. Sherwood,et al.  Intertask consistency of hemodynamic responses to laboratory stressors in a biracial sample of men and women. , 1994, International journal of psychophysiology : official journal of the International Organization of Psychophysiology.

[9]  N. Yanagisawa,et al.  Cytotoxicity of T cells for cerebral endothelium in multiple sclerosis , 1993, Journal of the Neurological Sciences.

[10]  H. Panitch Interferons in multiple sclerosis. A review of the evidence. , 1992, Drugs.

[11]  E. Stip,et al.  [Organic personality syndrome in multiple sclerosis and effect of stress on recurrent attacks]. , 1994, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[12]  A. Bamberger,et al.  Systemic interleukin‐1 α and interleukin‐2 secretion in response to acute stress and to corticotropin‐releasing hormone in humans * , 1994, European journal of clinical investigation.

[13]  G. Grau,et al.  Tumor necrosis factor alpha production as a possible predictor of relapse in patients with multiple sclerosis. , 1992, European cytokine network.

[14]  R. Hirsch,et al.  EXACERBATIONS OF MULTIPLE SCLEROSIS IN PATIENTS TREATED WITH GAMMA INTERFERON , 1987, The Lancet.

[15]  D. Silberberg,et al.  New diagnostic criteria for multiple sclerosis: Guidelines for research protocols , 1983, Annals of neurology.

[16]  B. Pentland,et al.  Cardiovascular reflexes in multiple sclerosis. , 1987, European neurology.

[17]  W. Sibley,et al.  A prospective study of physical trauma and multiple sclerosis. , 1991, Journal of neurology, neurosurgery, and psychiatry.

[18]  B. Rabin,et al.  Immunologic response to acute psychological stress in MS patients and controls , 1996, Journal of Neuroimmunology.

[19]  A P Smith,et al.  Negative life events, perceived stress, negative affect, and susceptibility to the common cold. , 1993, Journal of personality and social psychology.

[20]  G. Soma,et al.  Activation of the systemic production of tumor necrosis factor after exposure to acute stress. , 1992, European cytokine network.

[21]  O. J. Trask,et al.  Spousal caregivers of dementia victims: longitudinal changes in immunity and health. , 1991, Psychosomatic medicine.

[22]  M. Jensen,et al.  Interferon γ- and interleukin-4-secreting cells in multiple sclerosis , 1993, Journal of Neuroimmunology.

[23]  B. H. Fox,et al.  Short‐term immunological effects of induced emotion. , 1992, Psychosomatic medicine.

[24]  J. Kiecolt-Glaser,et al.  Immunological consequences of acute and chronic stressors: mediating role of interpersonal relationships. , 1988, The British journal of medical psychology.

[25]  H. Mcdevitt,et al.  Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases. , 1995, Immunology today.

[26]  T. Kamarck,et al.  A global measure of perceived stress. , 1983, Journal of health and social behavior.

[27]  E. Stip,et al.  Syndrome de personnalité organique dans la sclérose en plaque et influence du stress sur les poussées , 1994 .

[28]  C. Polman,et al.  Cardiovascular autonomic function in multiple sclerosis , 1991, Journal of the Neurological Sciences.

[29]  K. Matthews,et al.  Premenopausal and postmenopausal women differ in their cardiovascular and neuroendocrine responses to behavioral stressors. , 1989, Psychophysiology.

[30]  S. Levine,et al.  Nonspecific stress prevents relapses of experimental allergic encephalomyelitis in rats , 1987, Brain, Behavior, and Immunity.

[31]  S. Cohen,et al.  Stress and immunity in humans: a meta‐analytic review. , 1993, Psychosomatic medicine.

[32]  R. Heaton,et al.  Stress and Its Relationship to Acute Exacerbations in Multiple Sclerosis , 1988 .

[33]  R. Paul,et al.  Identifying multiple sclerosis patients with mild or global cognitive impairment using the Screening Examination for Cognitive Impairment (SEFCI) , 1995, Neurology.

[34]  W. Malarkey,et al.  Slowing of wound healing by psychological stress , 1995, The Lancet.

[35]  M. Jensen,et al.  Interferon gamma- and interleukin-4-secreting cells in multiple sclerosis. , 1993, Journal of neuroimmunology.

[36]  A. Blandino,et al.  Cardiovascular autonomic dysfunction in multiple sclerosis is likely related to brainstem lesions , 1993, Journal of the Neurological Sciences.

[37]  W. Paul,et al.  Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease , 1994, Journal of Neuroimmunology.

[38]  T. Olsson,et al.  Organ‐specific autoantigens induce interferon‐γ and interleukin‐4 mRNA expression in mononuclear cells in multiple sclerosis and myasthenia gravis , 1994, Neurology.

[39]  J. Kurtzke Rating neurologic impairment in multiple sclerosis , 1983, Neurology.

[40]  N. Yanagisawa,et al.  Increased interleukin-1 production by peripheral blood mononuclear cells in patients with multiple sclerosis , 1991, Journal of the Neurological Sciences.

[41]  S. Manuck,et al.  Stability of Individual Differences in Cellular Immune Responses to Acute Psychological Stress , 1995, Psychosomatic medicine.

[42]  C. Whitacre,et al.  Suppression of experimental autoimmune encephalomyelitis by restraint stress: Sex differences , 1993, Journal of Neuroimmunology.

[43]  A. Beck,et al.  Assessment of depression: the depression inventory. , 1974, Modern problems of pharmacopsychiatry.

[44]  J. Cacioppo,et al.  Autonomic cardiac control. III. Psychological stress and cardiac response in autonomic space as revealed by pharmacological blockades. , 1994, Psychophysiology.

[45]  R. Schiffer,et al.  Affective disorders in multiple sclerosis. Review and recommendations for clinical research. , 1990, Archives of neurology.

[46]  James F. Jones,et al.  Stress-related activation of Epstein-Barr virus , 1991, Brain, Behavior, and Immunity.

[47]  N. Schneiderman,et al.  The stability of cardiovascular parameters under different behavioral challenges: one-year follow-up. , 1993, International journal of psychophysiology : official journal of the International Organization of Psychophysiology.

[48]  Sydney B. Miller,et al.  Estradiol, progesterone and cardiovascular response to stress , 1996, Psychoneuroendocrinology.

[49]  B Neubauer,et al.  Analysis of heart rate variations in patients with multiple sclerosis. A simple measure of autonomic nervous disturbances using an ordinary ECG. , 1978, Journal of neurology, neurosurgery, and psychiatry.

[50]  K. Warren,et al.  Emotional stress and the development of multiple sclerosis: case-control evidence of a relationship. , 1982, Journal of chronic diseases.

[51]  C. Bever,et al.  Clinical trials of interferons in multiple sclerosis what have we learned? , 1993, Journal of Neuroimmunology.

[52]  Toshinori Mori,et al.  Restraint stress suppresses experimental allergic encephalomyelitis in Lewis rats , 1994, Brain Research Bulletin.

[53]  D. Schubert,et al.  Increased depression in multiple sclerosis patients. A meta-analysis. , 1993, Psychosomatics.

[54]  P. Albert,et al.  Retinoid treatment of experimental allergic encephalomyelitis. IL-4 production correlates with improved disease course. , 1995, Journal of immunology.

[55]  K. Mohler,et al.  Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery. , 1992, Journal of immunology.

[56]  A. Korczyn,et al.  Psychological stress as risk factor for exacerbations in multiple sclerosis , 1993, Neurology.

[57]  A. Broocks,et al.  Cytokine mRNA levels in mononuclear blood cells from patients with multiple sclerosis , 1994, Neurology.

[58]  R. Gräsbeck,et al.  Effects of psychological stress on plasma interleukins-1 beta and 6, C-reactive protein, tumour necrosis factor alpha, anti-diuretic hormone and serum cortisol. , 1993, Scandinavian journal of clinical and laboratory investigation.

[59]  A. Broocks,et al.  Tumor necrosis factor‐α messenger RNA expression in patients with relapsing‐remitting multiple sclerosis is associated with disease activity , 1995, Annals of neurology.

[60]  M. Rumsby,et al.  Cerebrospinal fluid interleukin 1 like activity during chronic relapsing experimental allergic encephalomyelitis. , 1987, Clinical and experimental immunology.

[61]  H. Northoff,et al.  The cytokine response to strenuous exercise. , 1994, International journal of sports medicine.

[62]  E. Kobayashi,et al.  Immune function in patients undergoing open vs laparoscopic cholecystectomy. , 1995, Archives of surgery.

[63]  T. Olsson Cytokine-producing cells in experimental autoimmune encephalomyelitis and multiple sclerosis , 1995, Neurology.

[64]  S. Cohen,et al.  Depression and immunity: a meta-analytic review. , 1993, Psychological bulletin.

[65]  I. Grant Psychosomatic-somatopsychic aspects of multiple sclerosis. , 1993 .

[66]  M. Huberman,et al.  Decreased IL-3 production by peripheral blood mononuclear cells in patients with multiple sclerosis , 1993, Journal of the Neurological Sciences.

[67]  C. Spielberger,et al.  Manual for the State-Trait Anxiety Inventory , 1970 .

[68]  S. Waugh,et al.  Experimental autoimmune encephalomyelitis is exacerbated by IL-1 alpha and suppressed by soluble IL-1 receptor. , 1991, Journal of immunology.

[69]  B. Arnason,et al.  Nervous system–immune system interactions and their role in multiple sclerosis , 1994, Annals of neurology.

[70]  D. Russell,et al.  The revised UCLA Loneliness Scale: concurrent and discriminant validity evidence. , 1980, Journal of personality and social psychology.